How Will The Pulmonary Embolism Market Expand At A CAGR Of 12.5% Through 2029?

Global Pulmonary Embolism Market

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Pulmonary Embolism Market?

In recent years, the market size for pulmonary embolism has seen a rapid expansion. It is projected to increase from $2.03 billion in 2024 to $2.26 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.4%. This notable growth throughout the historical period can be credited to factors such as anticoagulant therapies, research and clinical trials, heightened awareness of pulmonary embolism, and vte prophylaxis.

Over the coming years, the pulmonary embolism market is projected to experience accelerated growth, reaching a value of $3.62 billion by 2029 with a compound annual growth rate (CAGR) of 12.5%. This growth anticipated throughout the forecast period shall be influenced by factors such as targeted therapies, telemedicine and remote monitoring, health equity initiatives, and global health schemes. The future market trends will be dominated by elements like application of artificial intelligence in diagnosis, novel anticoagulants, creation of pulmonary embolism response teams and a greater focus on patient-centered care.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

What Drivers Are Accelerating Expansion Of The Pulmonary Embolism Market?

The growth of the pulmonary embolism market is anticipated to be propelled by the increasing occurrence of blood clots. Blood clots, also referred to as thrombi, are gel-like or semi-solid masses that form inside blood vessels. Pulmonary embolism risk is increased by blood clots as they can prevent blood from flowing freely to the lungs. Ordinarily, these blood clots lead to blockages, often in the deep veins of the legs, which then heightens the risk of pulmonary embolism. This was evidenced in April 2022 when Gavi, the Vaccine Alliance, an international body aimed at enhancing access to vaccines for children that are new or underused, published an article stating that scientists had detected a 33-fold surge in the likelihood of potentially lethal lung clots and a five-fold increase in the risk of deep vein thrombosis in the 30 days subsequent to COVID-19 exposure. As a result, the growing occurrence of blood clots is fuelling the expansion of the pulmonary embolism market.

What Are The Primary Segmentation Parameters In The Pulmonary Embolism Market?

The pulmonary embolismmarket covered in this report is segmented –

1) By Treatment: Medications; Mechanical Devices; Other Treatments

2) By Diagnosis: Chest X-Ray; Electrocardiogram (ECG); Magnetic Resonance Imaging (MRI); Computed Tomography Scan; Pulmonary Angiography; Venography; Venous Ultrasound; D-Dimer Test; Other Diagnosis

3) By Symptoms: Shortness Of Breath; Chest Pain; Cough; Irregular Heartbeat; Dizziness; Fever; Cyanosis; Other Symptoms

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users

Subsegments:

1) By Medications: Anticoagulants; Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters; Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy; Supportive Care

How Are Market Trends Influencing Competition In The Pulmonary Embolism Market?

Leading businesses in the pulmonary embolism marketplace are concentrating their efforts on creating cutting-edge products like the Triever16 Curve catheter and the RevCore thrombectomy catheter to establish competitive superiority. To illustrate, in June 2023, Inari Medical Inc., a medical device establishment based in the United States, introduced both the Triever16 Curve catheter and the RevCore thrombectomy catheter. The groundbreaking Triever16 Curve catheter is designed specifically for peripheral thrombectomy and pulmonary embolism procedures, offering superior trackability and a curve pre-shaped for concentrated aspiration. The catheter also sports a distinctive design enabling easy transition to larger and stronger 20F or 24F catheters. The RevCore thrombectomy catheter is constructed for treating venous in-stent thrombosis and functions as a mechanical thrombectomy apparatus, utilizing a nitinol basket to ensnare and remove blood clots. Further, these catheters enhance the safety and efficacy of pulmonary embolism operations.

Which Players Are Shaping The Competitive Landscape Of The Pulmonary Embolism Market?

Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck And Co.Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK PLC, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Penumbra Inc., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

What Are The Emerging Regional Trends Driving The Pulmonary Embolism Market?

North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp

Browse Through More Reports Similar to the Global Pulmonary Embolism Market 2025, By The Business Research Company

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model